Pharmacists in Merrimack, NH Accepting Medicare

21 Pharmacists found. Showing 1 - 20

Gregory Vestal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519

Stephen James Deminico Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-423-9330    Fax: 603-423-9336

Lauren Herrick West, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519

Renan Moretta Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4833    Fax: 603-424-4578

Mr. Brad A Valenti, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Continental Blvd, Merrimack, NH 03054 Phone: 603-429-0759    Fax: 603-429-0813

Dr. Meghan Armstrong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120

Nancy Delaney Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120

Dr. Lamia Bouziane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120

Katelyn S Roy, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Daniel Webster Hwy, Merrimack, Merrimack, NH 03054 Phone: 603-423-9330

Valarie Lynn Cataldi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 Wintergreen Dr, Merrimack, NH 03054 Phone: 603-424-2540

George H Kenson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30 Cota Rd, Merrimack, NH 03054 Phone: 603-424-3961

Abul Ansari Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120

Dr. Heather Layne Eggleston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Adams Ave, Merrimack, NH 03054 Phone: 781-724-2302

Mennatallah Mounir Sayed Mohamed Ibrahim Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Gilbert Dr Apt 203, Merrimack, NH 03054 Phone: 540-449-5239

Mrs. Elizabeth C Valenti, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 Marty Drive, Merrimack, NH 03054 Phone: 603-424-8833

Stacie Gordon, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Continental Blvd, Merrimack, NH 03054 Phone: 603-429-0759    Fax: 603-429-0813

Gayatri Yogesh Deshmukh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Continental Blvd, Merrimack, NH 03054 Phone: 603-429-0759

Dr. Wayne Arnold Dutch, RPH, PHARMD,CGP Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 52 Davis Rd, Merrimack, NH 03054 Phone: 603-424-7526    Fax: 603-424-7526

Dr. Islam Alrababah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 141 London Ct, Merrimack, NH 03054 Phone: 262-412-8488

Andrew Stephen Ball Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519

News Archive

HHS awards two contracts to accelerate flu vaccine availability

U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.

RadNet third quarter revenue increases 5.0% to record $140.1 million

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 192 fully-owned and operated outpatient imaging centers, today reported financial results, including record revenues, for its third quarter of 2010.

Pisgah to scale-up patent-pending form of hydrocodone

As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.

Acyclovir reduces occurrence of HSV-2 genital ulcers but does not affect HIV transmission

Research from a five-year international clinical study shows that acyclovir, a commonly prescribed drug used to suppress symptoms of the herpes virus, does not affect HIV transmission by people with both viruses.

Ardea Biosciences announces positive results from a phase 1 study of lead candidate for hyperuricemia and gout

Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).

Read more Medical News

› Verified 9 days ago

• 1(current)
• 2